Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In 2025, Ortho Development reported engagement with 84 surgeons and other clinicians in the states MedaRep covers, worth $478K in consulting, speaking, meals and travel for its device products, the most in Utah ($195K to 7). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Utah ($195K, 7 engaged), Virginia ($142K, 4 engaged), Maryland ($18K, 1 engaged), Montana ($17K, 1 engaged), Florida ($16K, 8 engaged).
In the last ten years FDA made 15 decisions for Ortho Development (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2018 (4). The latest was on 2025-12-19.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 9 |
| Cervical fusion & disc arthroplasty | 3 |
| Trivicta Hip Stem |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Ortho Development.